Skip to main content
Premium Trial:

Request an Annual Quote

Pharsight Gets New Senior VP; Aclara and Zyomyx Recruit Board Members; Lion Names Supervisory Board Head

NEW YORK, Aug. 1 - Pharsight chose Mona Sowiski to become its senior vice president for drug-development consulting, the company said yesterday.

 

Sowiski comes from marchFIRST, an Internet professional-services company, where she led its global health-care practice.

 


 

Zyomyx said yesterday it has tapped Michael Schmertzler and Nick Colangelo to join its board of directors.

 

Schmertzler comes from Credit Suisse First Boston Private Equity and Colangelo comes from Lilly BioVentures.

 


 

Aclara Bioscience has recruited Edward Hurwitz to its board of directors, the company said yesterday.

 

Hurwitz, who spent four years as senior vice president and chief operating officer at Affymetrix, is currently a venture partner at Alta Partners, a life-sciences venture capital company.

 


 

Lion Bioscience said on July 19 that it has named as head of its supervisory board J rgen Dormann.

 

Dormann, 62, helped create Aventis after bringing together Swiss pharma Hoechst and French pharma Rhône-Poulenc. He currently is the head of that company's supervisory board.

 



Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at
[email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics, that appears every Wednesday.
The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.